Skip to content

Acute Effect of Fructose on Lipid Metabolism and Gender Differences

Acute Effect of Fructose on Lipid Metabolism and Gender Differences

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00620360
Enrollment
18
Registered
2008-02-21
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2012-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Metabolism

Keywords

dietary fructose, plasma lipids, healthy humans, gender differences, hepatic de novo lipogenesis

Brief summary

It has been widely documented that fructose overfeeding increases plasma triglycerides and hepatic de novo lipogenesis, and impairs insulin sensitivity in healthy male volunteers. The effect of gender on the metabolic responses to fructose remains an important open question, however. The objective of this study is to compare the effect of an acute oral fructose load on carbohydrate and lipid metabolism in healthy young males and females.

Detailed description

The study is aimed at comparing the effects of oral fructose on several specific metabolic pathways in males and females.Participants will receive an isoenergetic diet containing 55% carbohydrate, 15% protein and 35% lipids for three days prior to testing. After this period of controlled diet, they will be studied for 2 hours in the post-absorptive state (Time 0-120 min) and over a 6 hours period (Time 120-480 min) during which they will receive 4 loads of 0,30 g/kg fat free mass U-13C labelled fructose, at times 120, 180, 240, 300. Throughout the study, deuterated glucose and glycerol will be infused to monitor whole body glucose production and glycerol turnover. The following parameters will be monitored in basal conditions and after the ingestion of the load of fructose: * Glycerol turnover(glycerol 2H5) * de novo lipogenesis (incorporation of 13C into palmitate of VLDLs) * whole body energy expenditure and net substrate oxydation (indirect calorimetry) * net fructose oxidation (breath 13CO2) * glucose turnover: (6,6 2H2 Glucose) * plasma glucose, free fatty acids, ketone bodies, lactate, insulin, triacylglycerol, total cholesterol, VLDL, LDL, and HDL subfractions An adipose tissue (periumbilical subcutaneous) biopsy will be obtaine by needle aspiration under local anesthesia in fasting conditions (time 0 min) and after fructose (time 480 min) to assess the effects of fructose on adipose gene expression profile. Key genes involved in the regulation of carbohydrate (GLUT 4, hexokinase, PDH-kinase), lipid (FAT-CD36, FABP, acetylCoA carboxylase, malonyl-CoA decarboxylase, PPARg) and energy metabolism (PGC-1a, UCP2)will be monitored Results obtained in males and females will be compared with two-way analysis of variance

Interventions

DIETARY_SUPPLEMENTfructose

acute administration of 4 times 0.3g fructose/kg lean body mass

DIETARY_SUPPLEMENTFructose

acute administration of 4 times 0.3 g/kg fat-free mass oral fructose

Sponsors

University of Lausanne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females * Age 18-35 * Healthy * Body mass indexes (BMI) between 19 and 25 kg/m2 * Informed consent obtained

Exclusion criteria

* Smokers * Alcohol intake \> 30g/day * Drug abuse * Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Hepatic de novo lipogenesisacute effect of dietary fructose (within 6 hours)

Secondary

MeasureTime frame
Whole body lipid oxidation, glucose turnover, glycerol turnover, plasma substrates, hormone and energy expenditure (free fatty acid, glucose, lactate, beta-hydroxybutyrate, glycerol, VLDL- Triglycerides and insulin) expression of key adipose genesacute effect of fructose (within 6 hours)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026